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Abstract 
Lecithin cholesterol acyltransferase (LCAT) is a plasma enzyme that remodels 
nascent high density lipoprotein (HDL) into a mature form called spherical HDL. 
The impeding of this critical step in reverse cholesterol transport (RCT, the 
transport of cholesterol from periphery cells to liver), leads to atherosclerosis. 
Our goal is to use computational chemistry and molecular modeling tools to 
build molecular models for LCAT and its complex with nascent HDL. The 
molecular models are constructed from low resolution structures of LCAT and 
LCAT-HDL complex obtained by small angle neutron scattering (SANS) with 
contrast variation. Ultimately, we combine various experimental data (SANS 
data, hydrogen-deuterium exchange tandem mass spectrometry, other 
biochemical data) with computational techniques (bioinformatics, molecular 
modeling, SANS modeling, protein-protein docking, molecular dynamics 
simulation) to produce a molecular model for LCAT and its complex with nascent 
HDL. The model will be used in the future to map the amino acid residues from 
LCAT and the protein component of nascent HDL (apoA1) involved in mutual 
interaction, and to identify LCAT residues interacting with the lipid phase of 
nascent HDL. 
  
